Medical Association Guidelines, Post-2002/Women’s Health Initiative Findings
The findings of the NIH’s Women’s Health Initiative Study in 2002 changed forever the way that HT had been understood to work and the wide range of benefits it was thought to have provided. In the decade since, researchers and practitioners have come to understand safer ways to prescribe estrogen and estrogen plus progesterone replacement therapy so that women seeking relief from menopause symptoms can access a safe hormone therapy that relieves symptoms without suffering from unwanted and dangerous side effects.
KeywordsHormone therapy FDA North American Menopause Society International Menopause Society American Association of Clinical Endocrinology
- 1.ACOG Committee on Gynecologic Practice. Committee opinion number 322, November 2005. Compounded bioidentical hormones. Obstet Gynecol 2005;106(5 part 1): 1139–40.Google Scholar
- 4.Sturdee DW, Pines A, International Menopause Society Writing Group, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20.Google Scholar
- 5.Sturdee DW, Pines A, on behalf of the International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20.Google Scholar